Resource Allocation for Brain Research in Europe (RABRE)

The EBC has worked with Stockholm Health Economics to review the current level of resource allocation to brain research in the EU. Partly funded by the EC, RABRE sought to build on the EBC’s previous finding that brain diseases represent 35% of the burden of all diseases in Europe. RABRE analysed both private and public funding of brain research in Europe and funding sources were categorised according to function or disease target.

A cross-country comparison of results for Europe was made, and these were compared with results for the US, which is considered the leader in brain research. RABRE also assessed the potential benefits that further funding of brain research in Europe would bring, relative to costs. It drew on the results of the CDBE study for comparative purposes. Studies of this nature are unprecedented in Europe, making RABRE a pioneering project in an area that is receiving increasing attention from both the research community and European policy-makers.

The RABRE project ended in June 2006. RABRE reports were published in 2006 in the European Journal of Neuroscience and are also to be found in the Publications section of this website.